Orthofix Medical Inc.
NASDAQ:OFIXMedical - Devices
+$0.03 today
- Market cap
- $269.42M
- Beta
- 0.71
- P/E (TTM)
- -6.2
- EPS (TTM)
- -$1.48
Volume 0.40M
Average 0.38M
OFIX Total Non-current Liabilities
All obligations due after more than one year.
Orthofix Medical Inc.NASDAQ: OFIX
Total Non-current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total non-current liabilities rises 31.6% from a year ago
Total non-current liabilities stood at $290.38M at the end of Q1 FY2026, up 31.6% from a year earlier and up 26.2% from the prior quarter. Over 3 fiscal years it compounded at +82.0% a year.
Context
- Total non-current liabilities amounted to 32.8% of total assets at the end of Q1 FY2026, up 5.9 pp from a year earlier.
- Total non-current liabilities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total non-current liabilities keeps rising in the next quarterly balance sheet after a +31.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 230.13M USD
- Year-over-year change
- +3.9%
- 4-year CAGR
- +61.5%
| Period | Period end | Total Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 230.13M | +3.9% |
| FY2024 | 2024-12-31 | 221.54M | +37.3% |
| FY2023 | 2023-12-31 | 161.36M | +323.0% |
| FY2022 | 2022-12-31 | 38.15M | +12.7% |
| FY2021 | 2021-12-31 | 33.86M | — |
Total Non-current Liabilities vs competitors
How OFIX compares with its peers on the latest reported figures
- OFIX's Mar 2026 total non-current liabilities of $290.38M is the 4th highest of the 11 companies compared; the peer median is $71.26M.
- Its year-over-year change of +31.6% is the 3rd highest of 11, against a peer median of -0.1%.
- Total non-current liabilities amounts to 32.8% of total assets for OFIX, versus a peer median of 21.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $714.64M | +1.7% | -8.3% | 91.3% | |
| Mar 2026 | $470.1M | -1.9% | -0.9% | 101.6% | |
| Apr 2026 | $406M | -35.0% | -2.3% | 37.3% | |
| Mar 2026 | $290.38M | +31.6% | +82.0% | 32.8% | |
| Mar 2026 | $136.8M | +4.3% | -24.7% | 13.0% | |
| Mar 2026 | $100.24M | +34.2% | +465.8% | 25.0% | |
| Mar 2026 | $42.29M | +17.3% | -2.1% | 17.4% | |
| Mar 2026 | $35.79M | -48.0% | -56.5% | 5.6% | |
| Mar 2026 | $35.12M | -3.1% | -4.7% | 12.3% | |
| Mar 2026 | $31.54M | +38.7% | +18.3% | 30.5% | |
| Mar 2026 | $3.59M | -43.6% | -37.0% | 1.8% | |
| Peer median (excluding OFIX) | $71.26M | -0.1% | -3.5% | 21.2% | |
Competitors are the stored peer set for OFIX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 87.85M | 50.7M | 33.11M | 83.24M | 82.03M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 78.56M | 82.86M | 128.1M | 134.71M | 135.75M |
| Inventory | 82.97M | 100.15M | 222.17M | 189.45M | 34.17M |
| Other Current Assets | 0 | 22.28M | 37.07M | 25.88M | 164.91M |
| Total Current Assets | 269.52M | 255.99M | 420.44M | 433.29M | 416.85M |
| Property, Plant & Equipment (Net) | 59.25M | 58.23M | 159.06M | 139.8M | (11.09M) |
| Goodwill | 71.32M | 71.32M | 194.93M | 194.93M | 194.93M |
| Intangible Assets | 52.67M | 47.39M | 117.49M | 98.8M | 72.77M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 1.77M | 0 | 0 | 0 | 254.63M |
| Other Non-current Assets | 22.1M | 25.71M | 33.39M | 26.47M | (77.44M) |
| Total Non-current Assets | 207.1M | 202.64M | 504.87M | 460.01M | 433.8M |
| Total Assets | 476.62M | 458.63M | 925.32M | 893.29M | 850.65M |
| Account Payables | 26.46M | 27.6M | 58.36M | 48.8M | 58.39M |
| Short-term Debt | 0 | 0 | 1.25M | 0 | 3.98M |
| Tax Payables | 4.66M | 6.59M | 7.59M | 8.41M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 21.99M | 0 | 1M | 7.1M | 81.08M |
| Total Current Liabilities | 105.83M | 83.62M | 165.22M | 168.63M | 170.48M |
| Long-term Debt | 0 | 0 | 93.11M | 157.02M | 182.8M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 6.08M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 13.97M | 18.91M | 49.72M | 46.69M | (1.23M) |
| Total Non-current Liabilities | 33.86M | 38.15M | 161.36M | 221.54M | 230.13M |
| Total Liabilities | 139.69M | 121.77M | 326.59M | 390.17M | 400.61M |
| Common Stock | 1.98M | 2.02M | 3.72M | 3.85M | 3.98M |
| Retained Earnings | 21M | 1.25M | (150.14M) | (276.14M) | (368.33M) |
| Accumulated OCI | 0 | (1.38M) | (1.29M) | (4.3M) | 618K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 336.93M | 336.86M | 598.73M | 503.12M | 450.04M |
| Total Debt | 24.31M | 21.53M | 117.07M | 179.63M | 229.26M |
| Net Debt | (63.53M) | (29.17M) | 83.97M | 96.39M | 147.24M |
Orthofix Medical Inc.
NASDAQ:OFIX
Intrinsic Alpha fair value
Locked
Current Price
$6.61
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.